Tilray | TRLY - 现金及等价物

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.63B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	现金及等价物	更改		日
Acasti Pharma	USD 16.86M		3.14M	2025-09
Akebia Therapeutics	USD 162.64M		22.2M	2026-03
Alaunos Therapeutics	USD 354K		1.03M	2026-03
Aurora Cannabis	CAD 56.36M		39.33M	2025-12
Avita Medical	AUD 10.24M		1.98M	2025-12
Canopy Growth	CAD 371.32M		73.26M	2025-12
Cronos Group	USD 791.79M		7.62M	2025-12
Dianthus Therapeutics	USD 627.67M		576.58M	2026-03
Divis Laboratories Ltd	INR 4.15B		31.87B	2025-03
Ionis Pharmaceuticals	USD 1.92B		758M	2026-03
IQVIA Holdings	USD 1.95B		33M	2026-03
Knight Therapeutics	CAD 76.45M		5.43M	2025-12
Moderna	USD 1.91B		687M	2026-03
Organigram Holdings	CAD 7.58M		20.62M	2025-12
Organon & Co	USD 1.12B		542M	2026-03
Revvity	USD 860.32M		59.54M	2026-03
Tectonic Therapeutic	USD 236.89M		16.9M	2026-03
Tilray	USD 264.83M		43.16M	2025-06
Viatris	USD 1.8B		481.8M	2026-03
Xeris Pharmaceuticals	USD 111.75M		708K	2026-03
Zealand Pharma A/S	4.58B		1.4B	2025-12